Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammed F Saad

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
European Journal of Endocrinology|May 11, 2004
Association of leptin receptor polymorphism with insulin resistanceKen C Chiu, Audrey Chu, Lee-Ming Chuang, et al.
Diabetes Technology & Therapeutics|January 8, 2004
Modeling beta-cell insulin secretion--implications for closed-loop glucose homeostasisGarry M Steil, Kerstin Rebrin, Robert Janowski, et al.
The American Journal of Clinical Nutrition|April 29, 2004
Hypovitaminosis D is associated with insulin resistance and beta cell dysfunctionKen C Chiu, Audrey Chu, Vay Liang W Go, et al.
Pancreas|July 29, 2003
New insulin sensitivity adjusted beta cell indices: validation according to a genetic studyKen C Chiu, Dorothy S Martinez, Nancy P Lee, et al.
Diabetes Technology & Therapeutics|May 3, 2003
Determination of plasma glucose during rapid glucose excursions with a subcutaneous glucose sensorGarry M Steil, Kerstin Rebrin, John Mastrototaro, et al.
Diabetes Care|March 1, 2003
Insulin sensitivity and the risk of incident hypertension: insights from the Insulin Resistance Atherosclerosis StudyDavid C Goff, Daniel J Zaccaro, Steven M Haffner, et al.
Diabetes|November 30, 2006
Feasibility of automating insulin delivery for the treatment of type 1 diabetesGarry M Steil, Kerstin Rebrin, Christine Darwin, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2002
Insulin regulates plasma ghrelin concentrationMohammed F Saad, Basem Bernaba, Chii-Min Hwu, et al.
Diabetes|November 30, 2006
Lipin deficiency impairs diurnal metabolic fuel switchingJun Xu, W N Paul Lee, Jack Phan, et al.
Diabetes Care|May 27, 2004
Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic subjects: a 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone armMohammed F Saad, Susan Greco, Kwame Osei, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
European Journal of Endocrinology|May 11, 2004
Association of leptin receptor polymorphism with insulin resistanceKen C Chiu, Audrey Chu, Lee-Ming Chuang, et al.
Diabetes Technology & Therapeutics|January 8, 2004
Modeling beta-cell insulin secretion--implications for closed-loop glucose homeostasisGarry M Steil, Kerstin Rebrin, Robert Janowski, et al.
The American Journal of Clinical Nutrition|April 29, 2004
Hypovitaminosis D is associated with insulin resistance and beta cell dysfunctionKen C Chiu, Audrey Chu, Vay Liang W Go, et al.
Pancreas|July 29, 2003
New insulin sensitivity adjusted beta cell indices: validation according to a genetic studyKen C Chiu, Dorothy S Martinez, Nancy P Lee, et al.
Diabetes Technology & Therapeutics|May 3, 2003
Determination of plasma glucose during rapid glucose excursions with a subcutaneous glucose sensorGarry M Steil, Kerstin Rebrin, John Mastrototaro, et al.
Diabetes Care|March 1, 2003
Insulin sensitivity and the risk of incident hypertension: insights from the Insulin Resistance Atherosclerosis StudyDavid C Goff, Daniel J Zaccaro, Steven M Haffner, et al.
Diabetes|November 30, 2006
Feasibility of automating insulin delivery for the treatment of type 1 diabetesGarry M Steil, Kerstin Rebrin, Christine Darwin, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2002
Insulin regulates plasma ghrelin concentrationMohammed F Saad, Basem Bernaba, Chii-Min Hwu, et al.
Diabetes|November 30, 2006
Lipin deficiency impairs diurnal metabolic fuel switchingJun Xu, W N Paul Lee, Jack Phan, et al.
Diabetes Care|May 27, 2004
Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic subjects: a 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone armMohammed F Saad, Susan Greco, Kwame Osei, et al.
Pageof 6